Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

HIV and multidrug-resistant tuberculosis: overlapping epidemics.

Dean AS, Zignol M, Falzon D, Getahun H, Floyd K.

Eur Respir J. 2014 Jul;44(1):251-4. doi: 10.1183/09031936.00205413. Epub 2014 Feb 13. No abstract available.

2.

Reversal of misfortunes.

Cohen J.

Science. 2013 Feb 22;339(6122):898-903. doi: 10.1126/science.339.6122.898. No abstract available. Erratum in: Science. 2013 Mar 8;339(6124):1149.

PMID:
23430629
3.

HIV and multidrug-resistant tuberculosis: overlapping risk factors.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Ismailov S.

Eur Respir J. 2015 Feb;45(2):567-9. doi: 10.1183/09031936.00131014. No abstract available.

4.

The tuberculosis and HIV epidemic in South Africa and the KwaZulu-Natal Research Institute for Tuberculosis and HIV.

Kasprowicz VO, Achkar JM, Wilson D.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1099-101. doi: 10.1093/infdis/jir414. No abstract available.

PMID:
21996691
5.

High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public-private initiative.

Villegas SL, Ferro BE, Perez-Velez CM, Moreira CA, Forero L, Martínez E, Rastogi N, Caminero JA.

Eur Respir J. 2012 Dec;40(6):1569-72. doi: 10.1183/09031936.00018212. No abstract available.

6.

Outbreak of hospital acquired multidrug resistant tuberculosis.

[No authors listed]

Commun Dis Rep CDR Wkly. 1995 Aug 25;5(34):161. No abstract available.

PMID:
7550589
7.

The 'bear trap': the colliding epidemics of tuberculosis and HIV in Russia.

Drobniewski FA, Atun R, Fedorin I, Bikov A, Coker R.

Int J STD AIDS. 2004 Oct;15(10):641-6. Review.

PMID:
15479497
8.

[Patterns of resistance to antitubercular agents in Girona. Diagnostic and therapeutic implications].

Camafort Babkowski M, Algarra Vento J, de Batlle Surroca J, García-Bragado Dalmau F.

Med Clin (Barc). 1997 Mar 22;108(11):438-9. Spanish. No abstract available.

PMID:
9213646
9.

Biomedical research. Hughes backs institute at epicenter of HIV and resistant TB.

Koenig R.

Science. 2009 Mar 27;323(5922):1659. doi: 10.1126/science.323.5922.1659. No abstract available.

PMID:
19325090
10.

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.

Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, Simpson J, Barnard M, Coetzee G, van Cutsem G, Goemaere E.

PLoS One. 2010 Nov 15;5(11):e13901. doi: 10.1371/journal.pone.0013901.

11.

Leaders warn of deadly HIV, TB collision.

Voelker R.

JAMA. 2008 Aug 6;300(5):491-2. doi: 10.1001/jama.300.5.491. No abstract available.

PMID:
18677016
12.

The re-emergence of tuberculosis.

Porter JD, McAdam KP.

Annu Rev Public Health. 1994;15:303-23. Review.

PMID:
8054087
13.

Multidrug-resistant tuberculosis and the need for biosocial perspectives.

Farmer P, Bayona J, Becerra M.

Int J Tuberc Lung Dis. 2001 Oct;5(10):885-6. No abstract available.

PMID:
11605879
14.

Improved data reveals higher global burden of tuberculosis.

[No authors listed]

Cent Eur J Public Health. 2014 Dec;22(4):228. No abstract available.

PMID:
25622479
15.

Surveillance of HIV and tuberculosis drug resistance.

Decosas J, Boillot F.

Lancet. 2005 Aug 6-12;366(9484):438-9. No abstract available.

PMID:
16084238
16.

Deadly HIV-TB co-epidemic in sub-Saharan Africa.

[No authors listed]

AIDS Read. 2008 Jan;18(1):15. No abstract available.

PMID:
18240447
17.

Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.

Clouse K, Blevins M, Lindegren ML, Yotebieng M, Nguyen DT, Omondi A, Michael D, Zannou DM, Carriquiry G, Pettit A; International Epidemiologic Databases to Evaluate AIDS (IeDEA) collaboration.

PLoS One. 2017 Feb 9;12(2):e0171384. doi: 10.1371/journal.pone.0171384. eCollection 2017.

18.

Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium.

Blasi F, Dara M, van der Werf MJ, Migliori GB.

Eur Respir J. 2013 Mar;41(3):491-4. doi: 10.1183/09031936.00196712. No abstract available.

19.

Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey.

Samo Gudo P, Cuna Z, Coelho E, Maungate S, Borroni E, Miotto P, Ahmadova S, Brouwer M, Migliori GB, Zignol M, Cirillo DM.

Eur Respir J. 2011 Jul;38(1):222-4. doi: 10.1183/09031936.00182010. No abstract available.

20.

Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.

Bates M, Ahmed Y, Chilukutu L, Tembo J, Cheelo B, Sinyangwe S, Kapata N, Maeurer M, O'Grady J, Mwaba P, Zumla A.

Trop Med Int Health. 2013 Sep;18(9):1134-1140. doi: 10.1111/tmi.12145. Epub 2013 Jul 3.

Supplemental Content

Support Center